Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

Maureen Rutten - van Molken, JB (Jan) Oostenbrink, M Miravitlles, BU Monz

Research output: Contribution to journalArticleAcademic

75 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)123-135
Number of pages14
JournalEuropean Journal of Health Economics (HEPAC)
Volume8
DOIs
Publication statusPublished - 2007

Cite this